Publications by authors named "Mulawarman Jayusman"
Zhongguo Fei Ai Za Zhi
September 2019
Article Synopsis
- The study compares the effectiveness of three EGFR-tyrosine kinase inhibitors (gefitinib, erlotinib, and afatinib) in treating advanced non-small cell lung cancer (NSCLC) patients with EGFR mutations in Indonesia.
- It involved a retrospective analysis of 88 NSCLC patients, focusing on outcomes like treatment response and progression-free survival (PFS), finding no significant differences in PFS among the three treatments.
- The results indicated that while afatinib may be linked to a longer PFS, all three treatments were similarly effective overall, suggesting the need for more research.
